Ovarian

Ovarian
2026-02-03T00:00:00.000+11:00
Ongoing

DESTINY-Ovarian01

DESTINY-Ovarian01
Ovarian

Phase 3, Open-label, Multicenter, Randomized Trial of Trastuzumab Deruxtecan with Bevacizumab Versus Bevacizumab Monotherapy as First‑line Maintenance Therapy in HER2‑Expressing Ovarian Cancer

Phase 3, Open-label, Multicenter, Randomized Trial of Trastuzumab Deruxtecan with Bevacizumab Versus Bevacizumab Monotherapy as First‑line Maintenance Therapy in HER2‑Expressing Ovarian Cancer

Trial overview

Clinical Area

Medical Oncology

Disease

Ovarian

Disease site

Gynaecology

Study Phase

III

Trial Identifiers

Registration number: NCT06819007

https://clinicaltrials.gov/study/NCT06819007

GenesisCare Location(s)
Principal Investigator(s)
Medical Oncologist

Dr Sally Baron-Hay

FRACP MBBS

Dr Sally Baron-Hay
Sally
Baron-Hay
View Profile
Profile Image - Dr Sally Baron-Hay

Clinical trials enquiries

Thank you for submitting.

Thank you for submitting.

We will be in touch within 24 hours

Form submission error

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

 

* Indicates a required field.

 

The flag of Australia has a dark blue field. It features the flag of the United Kingdom — the Union Jack — in the canton, beneath which is a large white seven-pointed star. A representation of the Southern Cross constellation, made up of one small five-pointed and four larger seven-pointed white stars, is situated on the fly side of the field. dropdown icon
search icon
    +61
    dropdown icon
    • ACT
    • NSW
    • NT
    • QLD
    • VIC
    • SA
    • TAS
    • WA

    Please refer to your hospitals process for inpatient referrals...

    Find a centre